Danaher Corporation
$ 212.58
-1.10%
13 Feb - close price
- Market Cap 151,941,087,000 USD
- Current Price $ 212.58
- High / Low $ 218.75 / 210.79
- Stock P/E 42.73
- Book Value 74.32
- EPS 5.03
- Next Earning Report 2026-04-21
- Dividend Per Share $1.28
- Dividend Yield 0.58 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.07 %
- 52 Week High 242.80
- 52 Week Low 170.19
About
Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are Life Sciences, Diagnostics, and Environmental & Applied Solutions.
Analyst Target Price
$264.86
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-01-28 | 2025-10-21 | 2025-07-22 | 2025-04-22 | 2025-01-29 | 2024-10-22 | 2024-07-23 | 2024-04-23 | 2024-01-30 | 2023-10-24 | 2023-07-25 | 2023-04-25 |
| Reported EPS | 2.23 | 1.89 | 1.8 | 1.88 | 2.14 | 1.71 | 1.72 | 1.92 | 2.09 | 2.02 | 2.05 | 2.36 |
| Estimated EPS | 2.19 | 1.72 | 1.64 | 1.64 | 2.16 | 1.57 | 1.57 | 1.71 | 1.91 | 1.88 | 2.02 | 2.26 |
| Surprise | 0.04 | 0.17 | 0.16 | 0.24 | -0.02 | 0.14 | 0.15 | 0.21 | 0.18 | 0.14 | 0.03 | 0.1 |
| Surprise Percentage | 1.8265% | 9.8837% | 9.7561% | 14.6341% | -0.9259% | 8.9172% | 9.5541% | 12.2807% | 9.4241% | 7.4468% | 1.4851% | 4.4248% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-04-21 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 1.94 |
| Currency | USD |
Previous Dividend Records
| Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-01-30 | 2025-10-31 | 2025-07-25 | 2025-04-25 | 2025-01-31 | 2024-10-25 | 2024-07-26 | 2024-04-26 | 2024-01-26 | 2023-10-27 |
| Amount | $0.32 | $0.32 | $0.32 | $0.32 | $0.27 | $0.27 | $0.27 | $0.27 | $0.24 | $0.27 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: DHR
2026-02-13 21:12:27
Danaher Corporation announced the retirement of Dr. Jessica L. Mega from its Board of Directors, effective February 5, 2026, due to other professional commitments. This change is considered a material governance event, though Danaher clarified there are no disagreements. Investors are advised to monitor the board's future appointments and how Danaher navigates sector pressures like constrained biotech funding and pricing challenges in China.
2026-02-13 11:26:33
Krilogy Financial LLC has acquired a new stake in Danaher Corporation (NYSE:DHR), purchasing 4,991 shares valued at approximately $1.06 million in the third quarter. Other institutional investors have also recently adjusted their positions in Danaher, which currently has 79.05% institutional ownership. Analysts have assigned Danaher a "Moderate Buy" rating with a consensus price target of $253.86.
2026-02-13 10:57:23
Avantor, Inc. (NYSE:AVTR) shares have dropped 27% in the last month, contributing to a 50% decline over the past year. The company's price-to-sales (P/S) ratio of 1x is significantly lower than the industry average, primarily due to declining revenues and a forecast for slower future growth compared to its peers. Investors appear to be reacting negatively to the company's past revenue shrinkage and its less optimistic growth outlook, suggesting that the current low P/S ratio is reflective of these concerns.
2026-02-13 07:27:54
Brady Corporation (BRC) stock has reached an all-time high of $95.51, following strong financial results for Q1 fiscal year 2026 that exceeded analyst expectations. The company reported adjusted EPS of $1.21 and revenue of $405.3 million, alongside maintaining a 43-year dividend payment streak. Despite these achievements, InvestingPro analysis suggests the stock might be slightly overvalued, with earnings due in seven days.
2026-02-12 20:57:39
Avantor Inc (AVTR) is a "grown-up growth play" in the life sciences sector, supplying critical materials, equipment, and services for biopharma and healthcare. While not a viral consumer brand, it's gaining attention on financial social media for its role as a "picks-and-shovels" provider in the healthcare and biotech gold rush. Investors are considering AVTR for its long-term potential tied to the expanding life science ecosystem, despite its less "meme-worthy" profile compared to larger rivals like Thermo Fisher Scientific.
2026-02-12 19:29:09
Danaher Corp (DHR) shares dropped 4.82% on February 12, trading at $209.38, which is 13.76% below its 52-week high but 22.44% above its 52-week low. Wall Street analysts forecast an average target price of $263.56, suggesting a 25.88% upside, while GuruFocus estimates a fair value of $245.36. The company currently holds an "Outperform" status based on analyst recommendations.
